Cresset Asset Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-24,206
| Closed | -$497K | – | 1944 |
|
|
2024
Q3 | $497K | Sell |
24,206
-4,487
| -16% | -$92.2K | ﹤0.01% | 1491 |
|
|
2024
Q2 | $642K | Buy |
28,693
+3,313
| +13% | +$74.1K | ﹤0.01% | 1287 |
|
|
2024
Q1 | $698K | Buy |
25,380
+2,803
| +12% | +$77.1K | ﹤0.01% | 1154 |
|
|
2023
Q4 | $688K | Buy |
22,577
+2,329
| +12% | +$71K | ﹤0.01% | 1037 |
|
|
2023
Q3 | $640K | Buy |
20,248
+503
| +3% | +$15.9K | ﹤0.01% | 1019 |
|
|
2023
Q2 | $805K | Buy |
+19,745
| New | +$805K | ﹤0.01% | 916 |
|
|
2022
Q2 | – | Sell |
-13,783
| Closed | -$1M | – | 1045 |
|
|
2022
Q1 | $1M | Sell |
13,783
-1,587
| -10% | -$115K | 0.01% | 406 |
|
|
2021
Q4 | $1.82M | Sell |
15,370
-29,873
| -66% | -$3.53M | 0.02% | 317 |
|
|
2021
Q3 | $6.07M | Sell |
45,243
-4,161
| -8% | -$558K | 0.08% | 99 |
|
|
2021
Q2 | $8M | Sell |
49,404
-7,032
| -12% | -$1.14M | 0.11% | 68 |
|
|
2021
Q1 | $4.53M | Buy |
56,436
+24,224
| +75% | +$1.94M | 0.07% | 96 |
|
|
2020
Q4 | $1.75M | Buy |
32,212
+2,081
| +7% | +$113K | 0.03% | 176 |
|
|
2020
Q3 | $599K | Buy |
30,131
+14,428
| +92% | +$287K | 0.01% | 343 |
|
|
2020
Q2 | $330K | Buy |
+15,703
| New | +$330K | 0.01% | 431 |
|